Sector News

Report: Private equity firms eyeing Bayer MaterialScience

October 23, 2014
Chemical Value Chain
Private equity firms are mulling possible offers for Bayer MaterialScience (BMS), the German life science company’s major polyurethanes and polycarbonates business, according to a report on Reuters, citing sources familiar with the situation. Analysts have already speculated that BMS, which could be worth around €10 billion ($12.7 billion) on a debt-free basis when it is separated from Bayer next year, might also attract an industry buyer keen to establish a leadership position in BMS’s value-added plastics markets. 
 
> Read the full article on the Chemical Week website
 
By Natasha Alperowicz
 

comments closed

Related News

September 22, 2023

ExxonMobil announces startup of $2-billion chemicals expansion in Baytown

Chemical Value Chain

ExxonMobil Corp. (Spring, Tex.) announced the startup of two new chemical production units at its Baytown, Texas, manufacturing facility. The $2 billion expansion is part of ExxonMobil’s long-term growth plans to deliver higher-value products from its U.S. Gulf Coast refining and chemical facilities.

September 22, 2023

Ineos acquires Eramet Titanium & Iron for €230 Million

Chemical Value Chain

Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.

September 22, 2023

Arxada appoints Sanjeev Rastogi as CEO

Chemical Value Chain

Arxada has appointed Sanjeev Rastogi as Chief Executive Officer (CEO), effective immediately. He succeeds Marc Doyle who led Arxada since its foundation and will join the company’s board of directors as a non-executive member.

How can we help you?

We're easy to reach